(NASDAQ:KZIA) announced positive news this morning from its phase 1 clinical trial. Shares are $2.14 and there are 3400 trades with 727k in volume. The stock has a 52-week high of $12.28 is currently up 22%
http://archive.fast-edgar.com/20220805/AW2ZE22EZC2R22Z2222R2CYQG3ASZZ22XI42/
[mstock id=”73007″ asset=”KZIA”]
NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.
